tradingkey.logo

Nyxoah SA

NYXH
5.020USD
+0.030+0.60%
收盤 11/06, 16:00美東報價延遲15分鐘
187.93M總市值
虧損本益比TTM

Nyxoah SA

5.020
+0.030+0.60%

關於 Nyxoah SA 公司

Nyxoah SA 是一家總部位於比利時的醫療設備生產公司。該公司專注於開發和商業化治療睡眠呼吸障礙的解決方案和服務。該系統由一個神經刺激器(植入在舌頭神經附近)和一個激活芯片(連接到一次性貼片,每晚由患者放置在下巴下方)組成。

Nyxoah SA簡介

公司代碼NYXH
公司名稱Nyxoah SA
上市日期Sep 18, 2020
CEOMr. Olivier Taelman
員工數量- -
證券類型Ordinary Share
年結日Sep 18
公司地址Rue Edouard Belin 12
城市MONT-SAINT-GUIBERT
上市交易所Euronext Brussels
國家Belgium
郵編1435
電話3226121755
網址https://www.nyxoah.com/
公司代碼NYXH
上市日期Sep 18, 2020
CEOMr. Olivier Taelman

Nyxoah SA公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.98M
+17.27%
Mr. John Landry
Mr. John Landry
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Maurits S. Boon
Dr. Maurits S. Boon
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Loic Moreau
Mr. Loic Moreau
President - International
President - International
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Ms. Virginia Kirby
Ms. Virginia Kirby
Independent Director
Independent Director
--
--
Mr. Christoph Eigenmann
Mr. Christoph Eigenmann
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Daniel G. Wildman
Mr. Daniel G. Wildman
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.98M
+17.27%
Mr. John Landry
Mr. John Landry
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Maurits S. Boon
Dr. Maurits S. Boon
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Loic Moreau
Mr. Loic Moreau
President - International
President - International
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Ms. Virginia Kirby
Ms. Virginia Kirby
Independent Director
Independent Director
--
--

收入明細

暫無數據
暫無數據
業務
地區
暫無數據

股東統計

更新時間: 9月24日 週三
更新時間: 9月24日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Cochlear Limited
15.05%
Taub (Robert)
10.62%
Monden (Anneliese)
7.86%
Gilde Healthcare Partners B.V.
7.85%
ResMed Inc
4.62%
其他
54.01%
持股股東
持股股東
佔比
Cochlear Limited
15.05%
Taub (Robert)
10.62%
Monden (Anneliese)
7.86%
Gilde Healthcare Partners B.V.
7.85%
ResMed Inc
4.62%
其他
54.01%
股東類型
持股股東
佔比
Individual Investor
22.07%
Corporation
19.66%
Venture Capital
7.85%
Investment Advisor/Hedge Fund
6.99%
Investment Advisor
6.16%
Hedge Fund
0.78%
Research Firm
0.16%
其他
36.33%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
74
8.21M
21.94%
-2.04M
2025Q2
69
25.16M
67.22%
-3.01M
2025Q1
70
26.40M
70.53%
-2.65M
2024Q4
73
25.60M
68.47%
-1.01M
2024Q3
72
23.51M
71.46%
-828.78K
2024Q2
72
23.54M
72.39%
-1.11M
2024Q1
64
20.89M
72.68%
+374.51K
2023Q4
59
21.08M
73.36%
-418.05K
2023Q3
66
19.86M
69.10%
-2.56M
2023Q2
66
20.66M
78.20%
+1.01M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Cochlear Limited
5.63M
15.05%
--
--
Aug 29, 2025
Taub (Robert)
3.98M
10.62%
+585.48K
+17.27%
Dec 31, 2024
Monden (Anneliese)
2.94M
7.86%
--
--
Dec 31, 2024
Gilde Healthcare Partners B.V.
2.94M
7.85%
--
--
Dec 31, 2024
ResMed Inc
1.73M
4.62%
--
--
Dec 31, 2024
Hambrecht (Jürgen)
1.34M
3.59%
--
--
Dec 31, 2024
Vestal Point Capital, LP
1.11M
2.98%
-288.43K
-20.57%
Sep 24, 2025
BNP Paribas Asset Management Belgium S.A.
742.38K
1.98%
--
--
Aug 31, 2025
BlackRock Financial Management, Inc.
683.64K
1.83%
-281.93K
-29.20%
Jun 30, 2025
Fidelity Management & Research Company LLC
679.59K
1.82%
-431.65K
-38.84%
Jun 30, 2025
查看更多

持股ETF

更新時間: 22 小時前
更新時間: 22 小時前
機構名稱
佔比
iShares Health Innovation Active ETF
0.07%
Avantis International Equity ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
SPDR Portfolio Europe ETF
0%
DFA Dimensional International Small Cap ETF
0%
Avantis International Small Cap Equity ETF
0%
iShares Health Innovation Active ETF
佔比0.07%
Avantis International Equity ETF
佔比0%
DFA Dimensional International Core Equity 2 ETF
佔比0%
SPDR Portfolio Europe ETF
佔比0%
DFA Dimensional International Small Cap ETF
佔比0%
Avantis International Small Cap Equity ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI